Patent · US Active

Inhalable liquid formulations of DNase I

US9603906B2 · kind B2 · utility

0Cited by

85References

19Claims

0Family size

Assignee

Protalix Ltd. · IL

Inventors

Yoseph Shaaltiel · Beit Hillel, IL
Uri Hanania · Carmiel, IL
Tali Kizhner · Sachnin, IL
Yulia Matiuhin · Pardes Hana-Karkur, IL
Liat Fux · Kiryat Motzkin, IL
Avidor Shulman · Rakefet, IL

Key dates

Filing date	Jan 31, 2013
Grant date	Mar 28, 2017
Priority date	—
Expiry date	Jan 31, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y302/01052
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An inhalable pharmaceutical composition for pulmonary administration comprising human DNase I and a liquid carrier and, more particularly, but not exclusively, to methods, liquid pharmaceutical inhalation devices and systems for the therapeutic use thereof are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.